GGTI-2418 | m-entrepreneurship.com

Product Name :
GGTI-2418

Search keywords :
GGTI-2418

drugId :
null

Target Vo:
Geranylgeranyl transferase type I

Target Vo Short Name :
GGTase 1

Moa_Name:
Geranylgeranyl transferase type I inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Prescient

Active Company_Name :
Prescient Therapeutics Ltd

Active Indication_Name:
Lymphoma, T-Cell, Peripheral

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD68 (YP5054) Mouse mAb manufacturer
Dihydrouracil-d4 site
CDK9 Antibody: CDK9 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 43 kDa, targeting to CDK9. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts